Publicação
Generic drugs and brand name products: An approach about excipients
| Resumo: | In general excipients are considered to be “inert”, however in certain patients under certain circumstances some of them have demonstrated some activity, with increasing reports of adverse reactions. Generic drugs are required to have the same active substances, strength, dosage form and rout of administration as the brand name product, but excipients could be different. The excipients that have recognized action or effects should be declared on the labelling of medicines, and are listed in the Guideline products for human use. |
|---|---|
| Autores principais: | Nogueira, Andreia |
| Outros Autores: | Carvalho, Leticia; Tavares, Raquel; Ribeiro, Maximiano; Coutinho, Paula; Roque, Fátima |
| Assunto: | Generic drugs Brand name drugs Excipients Adverse reactions Guidelines |
| Ano: | 2016 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Instituto Politécnico da Guarda |
| Idioma: | inglês |
| Origem: | Repositório Institucional do Instituto Politécnico da Guarda |
| Resumo: | In general excipients are considered to be “inert”, however in certain patients under certain circumstances some of them have demonstrated some activity, with increasing reports of adverse reactions. Generic drugs are required to have the same active substances, strength, dosage form and rout of administration as the brand name product, but excipients could be different. The excipients that have recognized action or effects should be declared on the labelling of medicines, and are listed in the Guideline products for human use. |
|---|